COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead.
作者信息
Gentile Francesco, Aimo Alberto, Forfori Francesco, Catapano Giosuè, Clemente Alberto, Cademartiri Filippo, Emdin Michele, Giannoni Alberto
机构信息
Fondazione Toscana G. Monasterio, Pisa, Italy.
Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
出版信息
Eur J Prev Cardiol. 2020 Sep;27(13):1442-1446. doi: 10.1177/2047487320932695. Epub 2020 Jun 17.
Abstract
摘要
相似文献
1
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead.新型冠状病毒肺炎与肺纤维化风险：提前规划的重要性。
Eur J Prev Cardiol. 2020 Sep;27(13):1442-1446. doi: 10.1177/2047487320932695. Epub 2020 Jun 17.
2
Long term respiratory complications of covid-19.新冠病毒病的长期呼吸系统并发症
BMJ. 2020 Aug 3;370:m3001. doi: 10.1136/bmj.m3001.
3
Temporal changes in computed tomography of COVID-19 pneumonia with perilobular fibrosis.新型冠状病毒肺炎伴小叶周围纤维化的计算机断层扫描的时间变化
Hong Kong Med J. 2020 Jun;26(3):250.e1-251.e2. doi: 10.12809/hkmj208490. Epub 2020 Apr 29.
4
Obesity and impaired metabolic health in patients with COVID-19.COVID-19 患者的肥胖和代谢健康受损。
Nat Rev Endocrinol. 2020 Jul;16(7):341-342. doi: 10.1038/s41574-020-0364-6.
5
Will the COVID-19 pandemic worsen the obesity epidemic?新冠疫情是否会加剧肥胖症流行？
Nat Rev Endocrinol. 2020 Sep;16(9):469-470. doi: 10.1038/s41574-020-0387-z.
6
Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2.新型冠状病毒肺炎中的多器官功能障碍：新型冠状病毒肺炎相关多器官功能障碍
Expert Rev Respir Med. 2020 Sep;14(9):865-868. doi: 10.1080/17476348.2020.1778470. Epub 2020 Jun 22.
7
COVID-19 and gastrointestinal symptoms: the dust has not settled yet.新型冠状病毒肺炎与胃肠道症状：尘埃尚未落定。
Expert Rev Gastroenterol Hepatol. 2020 Oct;14(10):877-878. doi: 10.1080/17474124.2020.1801415. Epub 2020 Aug 1.
8
Delirium: a missing piece in the COVID-19 pandemic puzzle.谵妄：新冠疫情拼图中缺失的一块。
Age Ageing. 2020 Jul 1;49(4):497-498. doi: 10.1093/ageing/afaa094.
9
Atrial Arrhythmias in COVID-19 Patients.新冠病毒感染患者的房性心律失常
JACC Clin Electrophysiol. 2020 Sep;6(9):1189-1190. doi: 10.1016/j.jacep.2020.05.015. Epub 2020 May 28.
10
Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.新型冠状病毒肺炎（COVID-19）与肺栓塞并存：双重病理诊断面临的挑战
Thorax. 2020 Sep;75(9):812-814. doi: 10.1136/thoraxjnl-2020-215011. Epub 2020 May 23.
引用本文的文献
1
Post-COVID-19 lung disease: utility of biochemical and imaging markers in uncovering residual lung inflammation and monitoring anti-inflammatory therapy, a prospective study.新冠后肺部疾病：生化和影像学标志物在发现残余肺部炎症及监测抗炎治疗中的应用，一项前瞻性研究
Eur J Nucl Med Mol Imaging. 2025 May 13. doi: 10.1007/s00259-025-07297-w.
2
A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD These authors contributed equally: Yining Xie, Guangshu Chen, and Weiling Wu.一种结合实验验证的生物信息学方法分析了阿奇霉素治疗特发性肺纤维化（IPF）和慢性阻塞性肺疾病（COPD）患者的新型冠状病毒肺炎（SARS-CoV-2）感染的疗效。 这些作者贡献相同：谢伊宁、陈广舒和吴维玲。
Sci Rep. 2025 Mar 23;15(1):10009. doi: 10.1038/s41598-025-94801-9.
3
Determination of both the expression and serum levels of epidermal growth factor and transforming growth factor β1 genes in COVID-19.新型冠状病毒肺炎中表皮生长因子和转化生长因子β1基因的表达及血清水平测定
Sci Rep. 2025 Mar 21;15(1):9771. doi: 10.1038/s41598-025-92304-1.
4
Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis.网络药理学与实验验证解析清肺化痰方抗肺纤维化作用。
PLoS One. 2024 Jun 24;19(6):e0305903. doi: 10.1371/journal.pone.0305903. eCollection 2024.
5
Quantitative CT Texture Analysis of COVID-19 Hospitalized Patients during 3-24-Month Follow-Up and Correlation with Functional Parameters.COVID-19住院患者3至24个月随访期间的定量CT纹理分析及其与功能参数的相关性
Diagnostics (Basel). 2024 Mar 5;14(5):550. doi: 10.3390/diagnostics14050550.
6
Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers.抗纤维化药物治疗特发性肺纤维化和 COVID-19 引起的肺纤维化：治疗方法和潜在的诊断生物标志物。
Int J Mol Sci. 2024 Jan 26;25(3):1562. doi: 10.3390/ijms25031562.
7
Long-Term Radiological Pulmonary Changes in Mechanically Ventilated Patients with Respiratory Failure due to SARS-CoV-2 Infection.新型冠状病毒肺炎（SARS-CoV-2）感染致呼吸衰竭机械通气患者的长期肺部影像学改变
Biomedicines. 2023 Sep 26;11(10):2637. doi: 10.3390/biomedicines11102637.
8
Spatial distribution of COVID-19 patients in Sri Lanka.斯里兰卡 COVID-19 患者的空间分布。
BMC Public Health. 2023 Sep 9;23(1):1755. doi: 10.1186/s12889-023-16481-2.
9
NOX-2 Inhibitors may be Potential Drug Candidates for the Management of COVID-19 Complications.NOX-2 抑制剂可能成为治疗 COVID-19 并发症的潜在药物候选物。
Curr Drug Res Rev. 2024;16(2):128-133. doi: 10.2174/2589977515666230706114812.
10
Pharmacological approaches to pulmonary fibrosis following COVID-19.新冠病毒感染后肺纤维化的药理学治疗方法。
Front Pharmacol. 2023 Jun 15;14:1143158. doi: 10.3389/fphar.2023.1143158. eCollection 2023.
本文引用的文献
1
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019.2019冠状病毒病所致急性呼吸窘迫综合征长期使用皮质类固醇治疗的理论依据
Crit Care Explor. 2020 Apr 29;2(4):e0111. doi: 10.1097/CCE.0000000000000111. eCollection 2020 Apr.
2
Cardiovascular disease and COVID-19: les liaisons dangereuses.心血管疾病与 COVID-19：危险的关联。
Eur J Prev Cardiol. 2020 Jul;27(10):1017-1025. doi: 10.1177/2047487320924501. Epub 2020 May 11.
3
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.SARS-CoV-2 与肾素血管紧张素系统相互作用的临床意义：美国心脏病学会评论专题周报。
J Am Coll Cardiol. 2020 Jun 23;75(24):3085-3095. doi: 10.1016/j.jacc.2020.04.028. Epub 2020 Apr 16.
4
Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses.SARS-CoV-2 核衣壳蛋白表位在分类上相关冠状病毒中的比较计算分析。
Microbes Infect. 2020 May-Jun;22(4-5):188-194. doi: 10.1016/j.micinf.2020.04.002. Epub 2020 Apr 14.
5
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病（COVID-19）的重症监护管理：挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
6
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.新型冠状病毒肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 May 5;172(9):629-632. doi: 10.7326/M20-0533. Epub 2020 Mar 12.
7
Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study.医院获得性严重急性呼吸综合征的长期骨骼和肺部后果：一项前瞻性队列研究的15年随访
Bone Res. 2020 Feb 14;8:8. doi: 10.1038/s41413-020-0084-5. eCollection 2020.
8
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.抗纤维化疗法治疗特发性肺纤维化以外的肺纤维化疾病。
Eur Respir Rev. 2019 Oct 1;28(153). doi: 10.1183/16000617.0022-2019. Print 2019 Sep 30.
9
Thin-Section Computed Tomography Manifestations During Convalescence and Long-Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS).严重急性呼吸综合征（SARS）患者恢复期及长期随访期间的薄层计算机断层扫描表现
Med Sci Monit. 2016 Aug 8;22:2793-9. doi: 10.12659/msm.896985.
10
Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome: a significant contributor to poor outcome.急性呼吸窘迫综合征中机械通气相关的肺纤维化：导致不良预后的重要因素。
Anesthesiology. 2014 Jul;121(1):189-98. doi: 10.1097/ALN.0000000000000264.
Zotero 插件